Hydrophilic Matrices
Hydrophilic Matrices - Related Videos
03:07
Hydrophilic Interaction Liquid Chromatography: A Technique to Separate Hydrophilic Polar Analytes Using Hydrophilic Beads
0 Views •
2025
This video demonstrates the principle of separation of hydrophilic polar compounds using hydrophilic interaction liquid chromatography. This technique helps in the purification of various polar analytes, including N-glycans.
07:58
Invasion Assay Using 3D Matrices
0 Views •
2023
The extracellular matrix (ECM) is a network of molecules that provide a structural framework for cells and tissues and helps facilitate intercellular communication. Three-dimensional cell culture techniques have been developed to more accurately model this extracellular environment for in vitro study. While many cell processes during migration through 3D matrices are similar to those required for movement across rigid 2D surfaces, including adherence, migration through ECM also requires cells...
09:01
A Protocol for the Production of Gliadin-cyanoacrylate Nanoparticles for Hydrophilic Coating
0 Views •
2016
This article presents a protocol for the production of protein-based nanoparticles that changes the hydrophobic surface to hydrophilic. The produced nanoparticle is an assembly of gliadin-cyanoacrylate diblock copolymers. Spray coating with the produced nanoparticle changes the surface of target material to a hydrophilic surface.
11:38
Preparation of Complaint Matrices for Quantifying Cellular Contraction
0 Views •
Cited by 115 •
2010
In this video, we demonstrate the experimental techniques used to fabricate compliant, extracellular matrix (ECM) coated substrates suitable for cell culture, and which are amenable to traction force microscopy and observing effects of ECM stiffness on cell behavior.
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
0 Views •
Cited by 5 •
2014
The BoTest Matrix botulinum neurotoxin (BoNT) detection assays rapidly purify and quantify BoNT from a range of sample matrices. Here, we present a protocol for the detection and quantification of BoNT from both solid and liquid matrices and demonstrate the assay with BOTOX, tomatoes, and milk.
FAQs
Gastrointestinal fluid first penetrates the polymer system, causing it to hydrate and swell. This produces a viscous gel layer around the dosage form. The gel limits and regulates further fluid movement, drug dissolution, and diffusion, so the active ingredient leaves the matrix progressively rather than becoming available all at once.
The gel layer acts as a changing barrier between gastrointestinal fluid and the incorporated active ingredient. Its viscosity influences how quickly fluid reaches the drug and how readily dissolved drug diffuses outward. As a result, gel formation directly connects polymer hydration with the timing and consistency of drug release.
Hydration and swelling do not remain static throughout administration. As the gel changes, the hydrated polymer matrix may gradually erode, removing material that contributes to the release barrier. This erosion provides an additional release pathway alongside fluid penetration, dissolution, and diffusion, allowing release behavior to change over the dosage form's lifetime.
The key condition is exposure to gastrointestinal fluids, because that initiates polymer hydration and swelling. The resulting gel state then governs fluid penetration, drug dissolution, and diffusion. Changes in the gel over time, including gradual erosion, influence how the active ingredient becomes available and help determine the overall release pattern.
In pharmaceutical formulation, the active ingredient is incorporated within a hydrophilic polymer system and prepared as an oral controlled-release tablet. After administration, gastrointestinal fluid activates the polymer, while the hydrated matrix regulates release. This workflow links the tablet's composition and exposure conditions to the intended prolongation of drug availability.
By extending the release of an active ingredient, these systems can prolong therapeutic action and reduce the need for frequent dosing. They may also help maintain more consistent drug concentrations. Clinically, those effects can support treatment management and improve adherence, particularly when simpler dosing is important for sustained medication use.